Acadia Pharmaceuticals (0A4W.LSE) Q2 2026 Earnings

May 6Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
0.02
0.15
0.29
0.42

Details

Expected EPS
0.050507
Actual EPS
0.02
Surprise EPS
-0.03
Surprise Percent
-60.4%

Description

⁨Acadia Pharmaceuticals⁩ (⁦0A4W.LSE⁩) has reported earnings of ⁦0.02⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts